Marinomed Biotech AG

About Marinomed Biotech AG

Marinomed Biotech AG is an innovative biopharmaceutical company focused on inventing, developing, and partnering clinically meaningful therapies. Marinomed’s powerful pipeline is based upon the proprietary technologies Marinosolv®- and Carragelose® for treating serious viral infectious diseases and autoreactive immune disorders. 

Under the brand Solv4U, Marinomed offers the Marinosolv® technology for customized formulation development to enhance solubility and bioavailability of target small molecules and peptides in all stages of drug development. Use of the technology is not limited to specific indications. 

Marinosolv® is a solubilization technology with a broad application potential, by significantly enhancing the bioavailability of highly hydrophobic small molecules or peptides. In its inhouse development programme, Marinomed is improving established APIs in the field of autoreactive immune disorders, such as Tacrosolv (solubilized tacrolimus for ophthalmic use) and Budesolv (solubilized Budesonide) for the tr...

  • AT
  • 2020
    On CPHI since
  • 50 - 99
    Employees
Company types
Manufacturer/Innovator
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022